Point72 Middle East FZE’s BioVie BIVI Stock Holding History

Point72 Middle East FZE’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7	Closed	-$5.86K	–	1566
2023 Q1	$5.86K	Buy	+7	New	+$4.64K	﹤0.01%	1513

Other funds holding BIVI

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Middle East FZE's BIVI Position: Q2 2023 in Review

Point72 Middle East FZE sold out of BioVie (BIVI) in Q2 2023, closing a stake of 7 shares — an estimated $5.86K sold.

Point72 Middle East FZE first reported a position in BIVI in Q1 2023 and held it in 1 quarter. The position peaked at $5.86K in Q1 2023. 53 funds tracked by Wall St. Rank hold BIVI as of Q2 2023.

Point72 Middle East FZE reported no remaining BioVie position as of Q2 2023 after selling out during the quarter.
Point72 Middle East FZE sold 7 BioVie shares in Q2 2023, an estimated $5.86K.
Point72 Middle East FZE first reported a position in BioVie in Q1 2023 and held it in 1 quarter.
Point72 Middle East FZE's BioVie position peaked at $5.86K in Q1 2023.
53 funds tracked by Wall St. Rank held BioVie as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.